Midweek Takeaway with Angus Forrest, Executive Chairman of Acuity Risk Management #ACRM
Season 6, Episode 31, Dec 14, 2023, 07:30 AM
Phil Carroll and Kevin Hornsby talk to Angus after the company recently announced a significant contract win and provided a trading update. Acuity's subsidiary, Acuity Risk Management Limited (ARM), secured its largest contract worth £561,000 for the STREAM®️ software platform, from a major British Government organization, contributing to over £1 million in total orders from this client in 2023. The company experienced strong order growth of £955,000 since April, with an expectation of more orders by year-end. Customer retention remains high at 96%, and forward contracted revenue stood at £2.9 million as of October 31, 2023. The sales pipeline has grown to £5.7 million, with a notable increase in partner contributions. ARM, now under the company’s ownership for seven months, has seen a 43% revenue growth in two years, with several significant contracts won recently. The company is progressing towards cash generative trading and profitable operations and Angus noted significant strides towards achieving the objectives set during the readmission phase.
Disclaimer & Declaration of Interest
The information, investment views, and recommendations in this podcast are provided for general information purposes only. Nothing in this podcast should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion
Disclaimer & Declaration of Interest
The information, investment views, and recommendations in this podcast are provided for general information purposes only. Nothing in this podcast should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion